Vestigial Like 1 (VGLL1) (C-Term) Peptide
-
- Target See all VGLL1 products
- VGLL1 (Vestigial Like 1 (VGLL1))
- Protein Region
- C-Term
- Origin
- Human, Mouse
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB)
- Sequence
- PEVYRVFPDR HLTPEVYHVF PDRHLTPEVY PDGRCGPLQH LVQQDRYQNH
- Characteristics
- This is a synthetic peptide designed for use in combination with anti-Vgll1 Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- Purification
- Purified
-
-
- Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Concentration
- 1 mg/mL
- Buffer
- Final peptide concentration is 1 mg/mL in PBS.
- Handling Advice
- Avoid repeated freeze-thaw cycles.
- Storage
- -20 °C
- Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- VGLL1 (Vestigial Like 1 (VGLL1))
- Synonyms
- TDU Peptide, VGL1 Peptide, RGD1564038 Peptide, VGLL1 Peptide, vgl1 Peptide, Tondu Peptide, vestigial like family member 1 Peptide, vestigial-like family member 1 Peptide, VGLL1 Peptide, Vgll1 Peptide, vgll1 Peptide
- Background
-
Vgll1 may act as a specific coactivator for the mammalian TEFs.
Alias Symbols: Tondu
Protein Size: 307 - Molecular Weight
- 35 kDa
- Gene ID
- 170828
- NCBI Accession
- NM_133251, NP_573514
- UniProt
- Q99NC0
-